Cephalosporin Cross-Reactivity in Patients with Ceftriaxone Allergy

Understanding the Mechanism of Cross-Reactivity

Cefazolin can generally be safely administered to patients with ceftriaxone allergy because these two cephalosporins have distinct side chain structures that do not cross-react, according to the American Academy of Allergy, Asthma, and Immunology 1
Cross-reactivity between cephalosporins depends primarily on similarity of R1 side chains, not the shared beta-lactam ring, as stated by the American Academy of Allergy, Asthma, and Immunology 1, 2
Cefazolin has a unique side chain structure that differs from ceftriaxone and appears to have very low cross-reactivity with other beta-lactams, as noted by the American Academy of Allergy, Asthma, and Immunology 1

If the patient had a severe reaction suggesting sensitivity to the beta-lactam ring itself, they could theoretically react to any beta-lactam antibiotic, according to the American Academy of Allergy, Asthma, and Immunology 1
The 2022 guidelines describe a rare outlier patient who was skin test-positive to all beta-lactam reagents tested, including cefazolin, ceftibuten, carbapenems, and aztreonam, indicating sensitivity to the beta-lactam ring itself, as reported by the American Academy of Allergy, Asthma, and Immunology 1
This represents an extremely uncommon scenario but should be considered in patients with multiple documented beta-lactam allergies, as stated by the American Academy of Allergy, Asthma, and Immunology 1

Skin testing is generally not required unless the patient has multiple documented cephalosporin allergies, according to the American Academy of Allergy, Asthma, and Immunology 1, 2
Consider skin testing with cefazolin before administration to rule out the rare possibility of beta-lactam ring sensitivity in patients with severe ceftriaxone reactions or multiple cephalosporin allergies, as recommended by the American Academy of Allergy, Asthma, and Immunology 1, 2